Fierce Pharma

DECEMBER 23, 2024

The company already moved to cut its entire commercial sales force following several FDA setbacks in its efforts to introduce sotagliflozin in diabetes.

FDA 243

FDA Sales 243

MedCity News

DECEMBER 23, 2024

From a marketing perspective, there are three significant trends to watch in 2025 strategic brand partnerships, AI-driven healthcare information delivery, and the fundamental shift in social media engagement paradigms. The post Healthcare Marketing: Key Trends Shaping 2025 appeared first on MedCity News.

Healthcare 99

Healthcare Healthcare Marketing Media 99

Fierce Pharma

DECEMBER 23, 2024

The FDA has approved Vertexs Alyftrek, a once-daily triple combination for the treatment of cystic fibrosis. But analysts have different views on how the switch from Vertex's twice-daily Trikafta will play out.

FDA 179

FDA 179

MedCity News

DECEMBER 23, 2024

Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare leaders. The post Healthcare Leaders Slam Exclusion of Key Healthcare Provisions in Spending Package appeared first on MedCity News.

Healthcare 77

Healthcare Healthcare Government 77

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 23, 2024

The FDA approved Novo Nordisk's tissue factor pathway inhibitor (TFPI) antagonist concizumab as a once-a-day treatment to prevent or curb the frequency of bleeding episodes in patients ages 12 and older who have hemophilia A or B with inhibitors. The green light follows a rejection in 2023 and a trial pause over safety concerns several years before that.

Safety 146

Safety FDA Patients 146

Impetus Digital

DECEMBER 23, 2024

Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. This transformative series will showcase the 2025 Pharma Toolkit for Virtual Medical Education, revealing groundbreaking virtual tools and strategies set to revolutionize how we engage and educate HCPs, patients, and teams.

Education 59

Education Medical Pharma Training 59

MedCity News

DECEMBER 23, 2024

Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 FDA approval in plaque psoriasis, now has positive data from two pivotal tests in psoriatic arthritis. Bristol Myers Squibb is trying to add new indications for the drug and stay ahead of competitors including Takeda Pharmaceutical. The post Bristol Myers Squibbs Sotyktu Meets Goals in Two Pivotal Psoriatic Arthritis Studies appeared first on MedCity News.

FDA 66

FDA Pharmaceutical Marketing Biopharma 66

Fierce Pharma

DECEMBER 23, 2024

Bristol Myers Squibb has reported positive results for two phase 3 trials of Sotyktu in adult patients who have psoriatic arthritis. Without revealing figures, BMS said that the POETYK PsA-1 and POETYK PsA-2 studies achieved their respective primary endpoints, as a significantly greater proportion of patients on Sotyktu achieved at least a 20 percent improvement in symptoms compared to those on placebo at Week 16.

Patients 146

Patients 146

Pharmaceutical Technology

DECEMBER 23, 2024

Lillys Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.

Prescription 66

Prescription Medicine FDA 66

MedCity News

DECEMBER 23, 2024

Ascensions May cyberattack compromised 5.6 million patients personal and health information, including Social Security numbers, credit card numbers and addresses. However, there is no evidence that any data was stolen from Acensions EHR or other clinical systems, the health system said. The post 5.6 Million Patients’ Data Stolen During Ascensions Ransomware Attack Earlier This Year appeared first on MedCity News.

Patients 100

Patients 100

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

DECEMBER 23, 2024

Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.

FDA 64

FDA 64

European Pharmaceutical Review

DECEMBER 23, 2024

Researchers in Australia have created an innovative drug delivery system that utilises a metalbiomolecule network (MBN) comprising of non-toxic metal ions together with phosphonate biomolecules, eg, DNA. As the MBN nanoparticles do not require complicated drug carriers and the materials are bio-compatible, the system has potential to boost successful drug development, according to first author Dr Wanjun Xu.

Engineering 52

Engineering Networking Safety Pharmaceutical 52

Pharmaceutical Technology

DECEMBER 23, 2024

GlobalData analysis sees Lilly's investment in UK life sciences as an opportunity to drive economic growth whilst improving public health.

59

59

Pharmaceutical Commerce

DECEMBER 23, 2024

Jon Hamrick, partner, Curatio Scientia Advisors, discusses upcoming industry challenges at this year's Trade & Channel Strategies Conference in Philadelphia.

52

52

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

DECEMBER 23, 2024

Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.

FDA 59

FDA Safety 59

PharmExec

DECEMBER 23, 2024

Approval was based on positive results from the Phase III balance study, where Tryngolza demonstrated a notable placebo-adjusted triglyceride reduction at 12 months.

Pharmaceutical 52

Pharmaceutical FDA 52

Pharmaceutical Technology

DECEMBER 23, 2024

Though still below boom levels seen a few years ago, 2024 compares favourably to 2023, and signs suggest that growth will continue into 2025.

59

59

PharmExec

DECEMBER 23, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

Advertisement

Pharmaceutical Technology

DECEMBER 23, 2024

SK bioscience and Sanofi have expanded their agreement to jointly develop pneumococcal conjugate vaccines (PCVs).

59

59

PharmaTech

DECEMBER 23, 2024

The company is voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1 mg/mL) 30 mL vials due to misleading labeling and its status as an unapproved drug.

52

52

Pharmaceutical Commerce

DECEMBER 23, 2024

How will supply chains in the space continue to develop?

Healthcare 52

Healthcare Healthcare 52

PharmaTech

DECEMBER 23, 2024

David McErlane, Group President of Biologics, Catalent, reacts to trends in cell and gene therapy development and manufacturing and comments on Catalent's ESG strategy to support people, the environment, and communities.

Manufacturing 52

Manufacturing 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Commerce

DECEMBER 23, 2024

The latest news for pharma industry insiders.

Pharma 52

Pharma Healthcare Healthcare 52

PharmaTech

DECEMBER 23, 2024

Dr Rupa Pike, Sr. Director & Global Head Strategic Alliances and Field Scientists for Cell Therapy, Catalent, shares insight on de-risking cell therapy programs using streamlined development and manufacturing platforms.

Manufacturing 52

Manufacturing 52

PharmExec

DECEMBER 23, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmaTech

DECEMBER 23, 2024

Pharmaceutical Technology chats with Roger Viney from ICE Pharma about bile acids in detail, including how they are useful in helping to improve drug solubility and absorption.

Pharma 52

Pharma Pharmaceutical 52

Advertisement

Distribution

PharmExec

DECEMBER 23, 2024

In this part of his Pharmaceutical Executive video interview, Peter Ax, CEO of UpScriptHealth, explores the key factors driving the increasing number of partnerships between telehealth and pharmaceutical/medical device companies.

Healthcare 52

Healthcare Healthcare Pharma Pharmaceutical 52

European Pharmaceutical Review

DECEMBER 23, 2024

ICH Q6A 1 and ICH Q6B 2 are now 25-years old and urgently in need of revision. 3 Many significant changes have occurred during this time, particularly in development and approval of biological products. At the turn of the century only four to five antibodies were approved, and all based on limited knowledge and understanding. Since then, there have been major advances in this field, including monoclonal antibodies (MAbs), other recombinant proteins, antibody drug conjugates (ADCs) and advanced t

Safety 52

Safety Pharmaceutical Manufacturing Management 52

PharmExec

DECEMBER 23, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Pharmacy Times

DECEMBER 23, 2024

The approval of the generic to liraglutide injection, currently in shortage, could help increase patient access to the type 2 diabetes treatment.

Patients 49

Patients FDA 49

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales